PL3386988T3 - Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie - Google Patents

Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie

Info

Publication number
PL3386988T3
PL3386988T3 PL16873289T PL16873289T PL3386988T3 PL 3386988 T3 PL3386988 T3 PL 3386988T3 PL 16873289 T PL16873289 T PL 16873289T PL 16873289 T PL16873289 T PL 16873289T PL 3386988 T3 PL3386988 T3 PL 3386988T3
Authority
PL
Poland
Prior art keywords
dihydropyranopyrimidinone
derivatives
novel
novel dihydropyranopyrimidinone
dihydropyranopyrimidinone derivatives
Prior art date
Application number
PL16873289T
Other languages
English (en)
Inventor
Kyungjin Kim
Uk-Il KIM
Ji Hye Yoon
Original Assignee
St Pharm Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by St Pharm Co., Ltd. filed Critical St Pharm Co., Ltd.
Publication of PL3386988T3 publication Critical patent/PL3386988T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • C07D491/044Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
    • C07D491/052Ortho-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring the oxygen-containing ring being six-membered
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
PL16873289T 2015-12-08 2016-12-01 Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie PL3386988T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020150173801A KR101777475B1 (ko) 2015-12-08 2015-12-08 신규한 디히드로피라노피리미디논 유도체 및 이들의 용도
PCT/KR2016/014061 WO2017099424A1 (en) 2015-12-08 2016-12-01 Novel dihydropyranopyrimidinone derivatives, and use thereof
EP16873289.9A EP3386988B1 (en) 2015-12-08 2016-12-01 Novel dihydropyranopyrimidinone derivatives, and use thereof

Publications (1)

Publication Number Publication Date
PL3386988T3 true PL3386988T3 (pl) 2022-01-03

Family

ID=59013440

Family Applications (1)

Application Number Title Priority Date Filing Date
PL16873289T PL3386988T3 (pl) 2015-12-08 2016-12-01 Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie

Country Status (8)

Country Link
US (1) US10336765B2 (pl)
EP (1) EP3386988B1 (pl)
JP (2) JP2018536692A (pl)
KR (1) KR101777475B1 (pl)
CN (1) CN108473504B (pl)
ES (1) ES2893001T3 (pl)
PL (1) PL3386988T3 (pl)
WO (1) WO2017099424A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ749946A (en) * 2016-06-30 2023-11-24 Yakult Honsha Kk Novel compound or pharmaceutically acceptable salt thereof
US20220315598A1 (en) * 2019-12-02 2022-10-06 Shanghai Yingli Pharmaceutical Co., Ltd Oxygen-containing Heterocyclic Compound, Preparation Method Therefor and Use Thereof
CN118284609A (zh) * 2021-12-01 2024-07-02 St制药株式会社 用于制备三唑并嘧啶酮衍生物的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
WO2013010092A1 (en) * 2011-07-13 2013-01-17 Novartis Ag 4-oxo-3,5,7,8-tetrahydro-4h-pyrano {4,3-d} pyrminidinyl compounds for use as tankyrase inhibitors
US9181266B2 (en) 2011-07-13 2015-11-10 Novartis Ag 2-piperidin-1-yl-acetamide compounds for use as tankyrase inhibitors
MX2014000536A (es) 2011-07-13 2014-12-05 Novartis Ag Compuestos de 4-piperidinilo para usarse como inhibidores de tanquirasa.
EP2812323B1 (en) 2012-02-09 2016-04-06 Merck Patent GmbH Tetrahydro-quinazolinone derivatives as tank and parp inhibitors
WO2013182546A1 (en) 2012-06-07 2013-12-12 F. Hoffmann-La Roche Ag Pyrazolopyrimidone and pyrazolopyridone inhibitors of tankyrase

Also Published As

Publication number Publication date
JP6930060B2 (ja) 2021-09-01
KR20170067299A (ko) 2017-06-16
EP3386988A4 (en) 2019-06-12
WO2017099424A1 (en) 2017-06-15
ES2893001T3 (es) 2022-02-07
JP2018536692A (ja) 2018-12-13
US20180362538A1 (en) 2018-12-20
EP3386988B1 (en) 2021-09-15
CN108473504A (zh) 2018-08-31
EP3386988A1 (en) 2018-10-17
JP2020147594A (ja) 2020-09-17
KR101777475B1 (ko) 2017-09-11
US10336765B2 (en) 2019-07-02
CN108473504B (zh) 2021-04-16

Similar Documents

Publication Publication Date Title
IL252346A0 (en) Heteroaryl compounds, their preparation and use
GB201512203D0 (en) Agents,uses and methods
SG11201608943VA (en) Substituted 4-phenylpiperidines, their preparaiton and use
IL252438B (en) fgf21 history and uses
EP3154972A4 (en) Azamophinan derivatives and use thereof
GB2588261B (en) Apparatus, use of the apparatus and arrangement
PL3157901T3 (pl) Preparaty, ich wytwarzanie i zastosowanie, oraz odpowiednie składniki
GB201512215D0 (en) Agents,uses and methods
GB201408673D0 (en) Medicaments,uses and methods
PT3166945T (pt) Derivados de triazolopirimidinona ou de triazolopiridinona inovadores e utilização dos mesmos
SG11201803584RA (en) 1,4-dicarbonyl-piperidyl derivatives
IL254241A0 (en) Etv2 and its uses
IL249122A0 (en) History of imidazole- or 4,2,1-triazole and their use
IL247531A0 (en) The history of ksuz, their preparation and uses
PT3350150T (pt) 1,1-difeniletilenos substituídos por alcenilfenoxilo, processos para a sua preparação e sua utilização
IL258217A (en) 2,3,4,5 tetrahydropyridin-6-amine derivatives
PL3386988T3 (pl) Nowe pochodne dihydropiranopirymidynonu i ich zastosowanie
PT3288575T (pt) Complexo de proteína-melanina bioassimilável, sua preparação e utilizações
IL249073A0 (en) Cytin-glucan complex, its preparation and uses
IL249897A0 (en) 2-oxo-4,3-dihydropyridine-5-carboxylates and their use
EP3166946A4 (en) Novel imidazotriazinone or imidazopyrazinone derivatives, and use thereof
GB2545167B (en) Cloches and use thereof
IL251930A0 (en) Anylhydroxy derivatives, their preparation and medical uses
GB201518375D0 (en) Agents,uses and methods
GB201512211D0 (en) Agents, uses and methods